Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleFDA Approves Aprocitentan for Treatment-Resistant HTN: Daily Dose.AuthorsJennings, SydneySubjectsUNITED States. Food &; Drug Administration; DRUG approval; HYPERTENSION; ENDOTHELINS; DRUG dosagePublicationPatient Care (Online), 2024, p1ISSN1939-1897Publication typeArticle